Retinoid/NN
differentiation/NN
therapy/NN
in/IN
promyelocytic/JJ
leukemia/NN
./.

Acute/JJ
promyelocytic/JJ
leukemia/NN
(/(
APL/NN
)/)
is/VBZ
a/DT
specific/JJ
type/NN
of/IN
acute/JJ
myeloid/JJ
leukemia/NN
characterized/VBN
by/IN
the/DT
morphology/NN
of/IN
the/DT
blast/NN
cells/NNS
,/,
a/DT
specific/JJ
t(15;17)/NN
translocation/NN
,/,
and/CC
risks/NNS
of/IN
definite/JJ
coagulopathy/NN
./.
=====
Recently/RB
this/DT
leukemia/NN
was/VBD
further/RB
characterized/VBN
by/IN
an/DT
exquisite/JJ
sensitivity/NN
to/TO
all-trans/JJ
retinoic/JJ
acid/NN
's/POS
differentiation/NN
effect/NN
and/CC
the/DT
production/NN
of/IN
a/DT
fusion/NN
gene/NN
altering/VBG
the/DT
gene/NN
of/IN
RARalpha/NN
and/CC
a/DT
novel/JJ
gene/NN
PML/NN
./.
=====
In/FW
vivo/FW
differentiation/NN
therapy/NN
with/IN
retinoids/NNS
in/IN
APL/NN
patients/NNS
follows/VBZ
strict/JJ
guidelines/NNS
related/JJ
both/CC
to/TO
the/DT
APL/NN
cell/NN
and/CC
the/DT
biodisposal/NN
of/IN
all-trans/JJ
retinoic/JJ
acid/NN
./.